Bone Marrow Aspirate Concentrate Is Equivalent to PRP for the Treatment of Knee OA at 1 Year: Response
- PMID: 33196703
- PMCID: PMC7607718
- DOI: 10.1177/2325967120964478
Bone Marrow Aspirate Concentrate Is Equivalent to PRP for the Treatment of Knee OA at 1 Year: Response
Conflict of interest statement
One or more of the authors has declared the following potential conflict of interest or source of funding: A.W.A. has received consulting fees from Arthrex; speaking fees from Arthrex, Smith & Nephew, and Ossur; and royalties from Arthrex. J.G.H. has received honoraria from Avanos Medical, Fidia Pharma, and Tenex Health and consulting fees from Ferring Pharmaceuticals and Fujifilm SonoSite. AOSSM has not conducted an independent investigation on the OPD and disclaims any liability or responsibility relating thereto.
Comment on
-
Bone Marrow Aspirate Concentrate Is Equivalent to PRP for the Treatment of Knee OA at 1 Year: Letter to the Editor.Orthop J Sports Med. 2020 Oct 30;8(10):2325967120960706. doi: 10.1177/2325967120960706. eCollection 2020 Oct. Orthop J Sports Med. 2020. PMID: 33195724 Free PMC article. No abstract available.
References
-
- Murray IR, Geeslin AG, Goudie EB, Petrigliano FA, LaPrade RF. Minimum Information for Studies Evaluating Biologics in Orthopaedics (MIBO): platelet-rich plasma and mesenchymal stem cells. J Bone Joint Surg Am. 2017;99(10):809–819. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials